Deletion of SHP2 obviously promotes diethylnitrosamine-induced HCC progression, the down-regulation of SHP2 is also observed in human hepatocellular, and SHP2 acts as a tumor-suppressor gene [25]. The gene discussed is PTPN11; the disease is neoplasm.